203 related articles for article (PubMed ID: 14228887)
1. TYPE OF ANTIBODY RESPONSE IN MICE IMMUNIZED WITH TRANSPLANTABLE TUMOURS.
TEE DE; WATKINS J; WANG M; GAMMACK DB
Nature; 1964 Oct; 204():391-3. PubMed ID: 14228887
[No Abstract] [Full Text] [Related]
2. COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS.
WAHREN B
Nature; 1965 Jan; 205():409-10. PubMed ID: 14243441
[No Abstract] [Full Text] [Related]
3. GROWTH AND MORPHOLOGY OF MOUSE LYMPHOMA CELLS IN DIFFUSION CHAMBERS.
HAYS EF
Proc Soc Exp Biol Med; 1964 Oct; 117():45-50. PubMed ID: 14219956
[No Abstract] [Full Text] [Related]
4. HISTOCOMPATIBILITY GENES OF MICE. V. FIVE NEW HISTOCOMPATIBILITY LOCI IDENTIFIED BY CONGENIC RESISTANT LINES ON A C57B 10 BACKGROUND.
SNELL GD; BUNKER HP
Transplantation; 1965 Mar; 3():235-52. PubMed ID: 14265497
[No Abstract] [Full Text] [Related]
5. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE.
BRADNER WT; BACHMAN S; PINDELL MH
Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273
[No Abstract] [Full Text] [Related]
6. Influence of infectious virus on the induction of transplantation resistance in the Friend tumor system.
McCoy JL; Fefer A; Glynn JP
Cancer Res; 1967 Dec; 27(12):2267-71. PubMed ID: 4866760
[No Abstract] [Full Text] [Related]
7. INHIBITION OF TUMOUR GROWTH IN IRRADIATED MICE BY SENSITIZED HOMOLOGOUS SPLEEN CELLS.
GARDNER PS; TRENCH CA; GREEN CA; BIRD T
Nature; 1964 Sep; 203():1295. PubMed ID: 14230219
[No Abstract] [Full Text] [Related]
8. Immunity in malignant disease.
Fairley GH
Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160
[No Abstract] [Full Text] [Related]
9. IMMUNOLOGICAL TOLERANCE AND THE CANCER PROBLEM.
HASEK M; SVOBODA J; KOLDOVSKY P
Philipp J Cancer; 1963; 5():535-9. PubMed ID: 14232627
[No Abstract] [Full Text] [Related]
10. POSSIBLE USE OF H-2 ANTIGENS AS POSITIVE SELECTIVE MARKERS IN HETEROGENEOUS CELL POPULATIONS.
HELLSTROEM KE
Nature; 1964 Feb; 201():893-5. PubMed ID: 14132782
[No Abstract] [Full Text] [Related]
11. [REDUCTION OF THE PLASMA CONCENTRATION OF THE CHARLOTTE FRIEND LEUKEMOGENIC VIRUS BY ADOPTIVE IMMUNOTHERAPY (GRAFT OF ALLOGENIC BONE MARROW)].
MATHE G; AMIEL JL
C R Hebd Seances Acad Sci; 1964 Dec; 259():4408-10. PubMed ID: 14256003
[No Abstract] [Full Text] [Related]
12. INFLUENCE OF IMPLANT SITE ON THE IMMUNOLOGIC RESPONSE OF UNCONDITIONED SYRIAN HAMSTERS TO HETEROTRANSPLANTABLE HUMAN TUMORS.
YOHN DS; HAMMON WM; ATCHISON RW
Cancer Res; 1965 May; 25():484-9. PubMed ID: 14297486
[No Abstract] [Full Text] [Related]
13. PATTERNS OF CELLULAR DIFFERENTIATION IN SPONTANEOUS AND TRANSPLANTED LYMPHOMATA IN MICE.
METCALF D; NAKAMURA K; WIADROWSKI M
Aust J Exp Biol Med Sci; 1965 Jul; 43():413-20. PubMed ID: 14343502
[No Abstract] [Full Text] [Related]
14. Antigenic variant (WFT-2N) of a transplantable rat tumor induced by Friend virus.
Kobayashi H; Shirai T; Takeichi T; Hosokawa M; Saito H; Sendo F; Kodama T
Rev Eur Etud Clin Biol; 1970 Apr; 15(4):426-8. PubMed ID: 4912171
[No Abstract] [Full Text] [Related]
15. The effect of bone marrow transplantation on the survival of tumor-bearing patients and animals.
Ishibashi Y
Jpn J Exp Med; 1965 Oct; 35(5):419-32. PubMed ID: 5324183
[No Abstract] [Full Text] [Related]
16. Immunosuppression versus immunity in syngeneic and allogeneic tumours.
Vlachov K; Nouza K
Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871
[No Abstract] [Full Text] [Related]
17. IMMUNITY TO VIRUS-INDUCED TUMORS.
SJOGRAN HO
Proc Can Cancer Conf; 1963; 5():377-86. PubMed ID: 14278867
[No Abstract] [Full Text] [Related]
18. IMMUNE RESPONSE ENGENDERED IN MICE BY MULTIPARITY.
KALISS N; DAGG MK
Transplantation; 1964 May; 2():416-25. PubMed ID: 14144354
[No Abstract] [Full Text] [Related]
19. Interaction between tumor and host during progressive neoplastic growth in histoincompatible recipients.
Möller E
J Natl Cancer Inst; 1965 Dec; 35(6):1053-9. PubMed ID: 5856680
[No Abstract] [Full Text] [Related]
20. THYMUS CELL DIFFERENTIATION IN RELATION TO DEVELOPMENT OF IMMUNE RESPONSE AND SUSCEPTIBILITY TO LEUKEMOGENIC VIRUS.
MILLER JF
Acta Unio Int Contra Cancrum; 1964; 20():1536-40. PubMed ID: 14242950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
